T-duality and Actions for Non-BPS D-branes

We employ T-duality to restrict the tachyon dependence of effective actions for non-BPS D-branes. For the Born-Infeld part the criteria of T-duality and supersymmetry are satisfied by a simple extension of the D-brane Born-Infeld action.Comment: Latex, 11 page

Weyl multiplets of N=2 conformal supergravity in five Dimensions

We construct the Weyl multiplets of N=2 conformal supergravity in five dimensions. We show that there exist two different versions of the Weyl multiplet, which contain the same gauge fields but differ in the matter field content: the Standard Weyl multiplet and the Dilaton Weyl multiplet. At the linearized level we obtain the transformation rules for the Dilaton Weyl multiplet by coupling it to the multiplet of currents corresponding to an on-shell vector multiplet. We construct the full non-linear transformation rules for both multiplets by gauging the D=5 superconformal algebra F^2(4). We show that the Dilaton Weyl multiplet can also be obtained by solving the equations of motion for an improved vector multiplet coupled to the Standard Weyl multiplet.Comment: 40 pages, v2: note added and minor corrections; v3: corrections in (3.19-23); v4: + sign added in (3.19

The map between conformal hypercomplex/hyper-Kaehler and quaternionic(-Kaehler) geometry

We review the general properties of target spaces of hypermultiplets, which are quaternionic-like manifolds, and discuss the relations between these manifolds and their symmetry generators. We explicitly construct a one-to-one map between conformal hypercomplex manifolds (i.e. those that have a closed homothetic Killing vector) and quaternionic manifolds of one quaternionic dimension less. An important role is played by '\xi-transformations', relating complex structures on conformal hypercomplex manifolds and connections on quaternionic manifolds. In this map, the subclass of conformal hyper-Kaehler manifolds is mapped to quaternionic-Kaehler manifolds. We relate the curvatures of the corresponding manifolds and furthermore map the symmetries of these manifolds to each other.Comment: 54 pages, 2 figures; v2: small corrections, version to be published in CMP; v3: changes of statement on (3.5

N=2 supergravity in five dimensions revisited

We construct matter-coupled N=2 supergravity in five dimensions, using the superconformal approach. For the matter sector we take an arbitrary number of vector-, tensor- and hyper-multiplets. By allowing off-diagonal vector-tensor couplings we find more general results than currently known in the literature. Our results provide the appropriate starting point for a systematic search for BPS solutions, and for applications of M-theory compactifications on Calabi-Yau manifolds with fluxes.Comment: 35 pages; v.2: A sign changed in a bilinear fermion term in (5.7

Exploring Outcomes to Consider in Economic Evaluations of Health Promotion Programs: What Broader Non-Health Outcomes Matter Most?

Background Attention is increasing on the consideration of broader non-health outcomes in economic evaluations. It is unknown which non-health outcomes are valued as most relevant in the context of health promotion. The present study fills this gap by investigating the relative importance of non-health outcomes in a health promotion context. Method We investigated the relative importance of ten non-health outcomes of health promotion programs not commonly captured in QALYs. Preferences were elicited from a sample of the Dutch general public (N = 549) by means of a ranking task. These preferences were analyzed using Borda scores and rank-ordered logit models. Results The relative order of preference (from most to least important) was: self-confidence, insights into own (un)healthy behavior, perceived life control, knowledge about a certain health problem, social support, relaxation, better educational achievements, increased labor participation and work productivity, social participation, and a reduction in criminal behavior. The weight given to a particular non-health outcome was affected by the demographic variables age, gender, income, and education. Furthermore, in an open question, respondents mentioned a number of other relevant non-health outcomes, which we classified into outcomes relevant for the individual, the direct social environment, and for society as a whole. Conclusion The study provides valuable insights in the non-health outcomes that are considered as most important by the Dutch general population. Ideally, researchers should include the most important non-health outcomes in economic evaluations of health promotio

Improved range of motion after manipulation under anesthesia versus physiotherapy for stage two frozen shoulder:a randomized controlled trial

Background: Frozen shoulder (FS) is a common cause of shoulder pain and stiffness. Conservative treatment is sufficient for the majority of patients with long-term recovery of shoulder function. Manipulation under anesthesia (MUA) is known as a well-established treatment option if conservative treatment fails. It is unknown whether MUA does indeed shorten the duration of symptoms or leads to a superior outcome compared to conservative treatment. The objective of the current trial is to evaluate the effectiveness of MUA followed by a physiotherapy (PT) program compared to a PT program alone in patients with stage 2 FS. Methods: A prospective, single-center randomized controlled trial was performed. Patients between 18 and 70 years old with stage 2 FS were deemed eligible if an initial course of conservative treatment consisting of PT and intra-articular corticosteroid infiltration was considered unsatisfactory. Patients were randomized, and data was collected with an online data management platform (CASTOR). MUA was performed by a single surgeon under interscalene block, and intensive PT treatment protocol was started within 4 hours after MUA. In the PT group, patients were referred to instructed physiotherapist, and treatment was guided by tissue irritability. The primary outcome was the Shoulder Pain and Disability Index (SPADI) score. Secondary outcomes were pain, range of motion (ROM), Oxford Shoulder Score, quality of life, and ability to work. Results: In total, 82 patients were included, 42 in the PT group and 40 in the MUA group. There was a significant improvement in SPADI, Oxford Shoulder Score, pain, ROM, and quality of life in both groups at 1-year follow-up. SPADI scores at three months were significantly improved in favor of MUA. MUA showed a significantly bigger increase in anteflexion and abduction compared to PT at all points of follow-up. No significant differences between both groups were found for all other parameters. No fractures, dislocations, or brachial plexus injuries occurred in this trial. Conclusion: MUA in stage 2 FS can be considered safe and results in a faster recovery of ROM and improved functional outcome, measured with SPADI scores, compared to PT alone in the short term. After 1 year, except for slightly better ROM scores for MUA, the result of MUA is equal to PT.</p

Improved range of motion after manipulation under anesthesia versus physiotherapy for stage two frozen shoulder:a randomized controlled trial

Background: Frozen shoulder (FS) is a common cause of shoulder pain and stiffness. Conservative treatment is sufficient for the majority of patients with long-term recovery of shoulder function. Manipulation under anesthesia (MUA) is known as a well-established treatment option if conservative treatment fails. It is unknown whether MUA does indeed shorten the duration of symptoms or leads to a superior outcome compared to conservative treatment. The objective of the current trial is to evaluate the effectiveness of MUA followed by a physiotherapy (PT) program compared to a PT program alone in patients with stage 2 FS. Methods: A prospective, single-center randomized controlled trial was performed. Patients between 18 and 70 years old with stage 2 FS were deemed eligible if an initial course of conservative treatment consisting of PT and intra-articular corticosteroid infiltration was considered unsatisfactory. Patients were randomized, and data was collected with an online data management platform (CASTOR). MUA was performed by a single surgeon under interscalene block, and intensive PT treatment protocol was started within 4 hours after MUA. In the PT group, patients were referred to instructed physiotherapist, and treatment was guided by tissue irritability. The primary outcome was the Shoulder Pain and Disability Index (SPADI) score. Secondary outcomes were pain, range of motion (ROM), Oxford Shoulder Score, quality of life, and ability to work. Results: In total, 82 patients were included, 42 in the PT group and 40 in the MUA group. There was a significant improvement in SPADI, Oxford Shoulder Score, pain, ROM, and quality of life in both groups at 1-year follow-up. SPADI scores at three months were significantly improved in favor of MUA. MUA showed a significantly bigger increase in anteflexion and abduction compared to PT at all points of follow-up. No significant differences between both groups were found for all other parameters. No fractures, dislocations, or brachial plexus injuries occurred in this trial. Conclusion: MUA in stage 2 FS can be considered safe and results in a faster recovery of ROM and improved functional outcome, measured with SPADI scores, compared to PT alone in the short term. After 1 year, except for slightly better ROM scores for MUA, the result of MUA is equal to PT.</p

Myotube growth is associated with cancer-like metabolic reprogramming and is limited by phosphoglycerate dehydrogenase

Funding Information: Brendan M. Gabriel was supported by fellowships from the Novo Nordisk Foundation ( NNF19OC0055072 ) & the Wenner-Gren Foundation , an Albert Renold Travel Fellowship from the European Foundation for the Study of Diabetes , and an Eric Reid Fund for Methodology from the Biochemical Society . Abdalla D. Mohamed was funded initially by Sarcoma UK (grant number SUK09.2015 ), then supported by funding from Postdoctoral Fellowship Program ( Helmholtz Zentrum München, Germany ), and currently by Cancer Research UK . Publisher Copyright: © 2023 The AuthorsPeer reviewedPublisher PD